Jonathan Zalevsky
Company: Nektar
Job title: Chief Research & Development Officer
Seminars:
Rezpegaldesleukin, a Regulatory T-Cell Selective IL-2 Conjugate: Lessons Learned From Preclinical Design to Clinical Evaluation in Inflammatory Skin Diseases Including Atopic Dermatitis 12:00 pm
Use of the appropriate design elements and experimental models for generation and preclinical evaluation Using clinical development approaches to address target engagement and assess PK/PD principles Using clinical studies to identify the correlation between the MOA and the indicationRead more
day: Day Two AM Non-Cell Based Approaches